Holland Capital invests in Pluggerz
Amsterdam, Doetinchem, 11th of March 2026 – Holland Capital invests in Pluggerz, a market leader in custom-made hearing protection. Through this partnership, Pluggerz will be able to further strengthen its position and respond to the structurally increasing demand for hearing protection solutions.
Regulation and prevention awareness drive structural market growth
The market for hearing protection is growing, driven by stricter regulations regarding workplace noise exposure and the increasing responsibility of employers to actively prevent hearing damage. At the same time, societal awareness around hearing loss is increasing. Younger generations in particular are increasingly choosing structural protection.
Custom-made hearing protection
Pluggerz has been the hearing protection specialist of the Netherlands for 40 years and is the market leader in custom-made hearing protection. In addition, the company produces universal hearing protection and components for hearing aids. The organization combines high-quality customized products with advanced 3D printing technology, in-house R&D, and close collaboration with audiologists for personal fitting.
Investment for growth
The investment by Holland Capital enables Pluggerz to solidify its positions as market leader and invest strategically to fully benefit from the growing demand for hearing protection products.
Hubert Verbeek, Managing Partner Holland Capital: “We look forward to supporting Pluggerz in its development and contributing to the broader adoption of hearing protection. With our Healthcare and Technology expertise, we can help Pluggerz realize commercial acceleration and sustainable value creation.”
About Pluggerz
Pluggerz employs more than 90 people and operates from Doetinchem, where production and office activities take place under one roof. From its own production facilities, the company delivers quickly and efficiently to customers both domestically and internationally. Pluggerz develops and produces components for hearing aids and universal hearing protection for audiology, retail, and industrial clients. In addition, the organization collaborates with a social workshop and actively contributes to inclusive and sustainable employment in the region.
About Holland Capital
For more than 40 years, Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies in which it invests, with the shared goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare and Technology sectors. The firm understands the dynamics and opportunities in these sectors and has an extensive network.
The Key Information Document (KID) of this transaction in Dutch can be found here.
Holland Venture start nieuw private equity fonds
Amsterdam, 1 juli 2009 - Holland Venture heeft een nieuw private equity fonds van 70 miljoen euro opgezet dat zich richt op groei- en buy-out investeringen in de Benelux. De doelgroep van het fonds bestaat uit bestaande ondernemingen met een ondernemingswaarde tussen...
Verkoop Orthos Europe BV aan Atrium Innovations Inc.
Amsterdam, 22 september 2008 - Holland Venture heeft vandaag haar meerderheidsbelang in Orthos Europe BV verkocht. Orthos Europe BV houdt 100% van de aandelen van AOV Orthomoleculaire Voedingssupplementen BV, een onderneming die hooggedoseerde voedingssupplementen...
Holland Venture verkoopt haar meerderheidsbelang in Sunday’s International aan het management van de onderneming
Amsterdam, 9 juni 2008 - Holland Venture heeft haar meerderheidsbelang in Sunday’s International verkocht aan het management van de onderneming onder leiding van algemeen directeur Rob Bontje. Holland Venture realiseert hiermee een aantrekkelijk rendement op het...
Holland Venture verkoopt haar aandelen in INS Group S.A.
Amsterdam, 12 september 2007 - Holland Venture is verheugd om u te kunnen melden dat zij haar aandelen in INS Group, een in België gevestigd netwerk and systemen integrator, aan BT verkocht heeft. Met BT is overeengekomen dat zij 100% van de aandelen in INS Group...
Vacature Investment Analyst Healthcare BO
Investment Manager buy-out HealthcareInvestment Manager buy-out Healthcare Sector: Private Equity en Venture Capital Locatie: Amsterdam Opleidingsniveau: WO Over onze organisatie Holland Capital is een succesvolle participatiemaatschappij welke zich richt op...
CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei
CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei Eindhoven, 25 maart 2019 - CytoSMART, de Eindhovense ontwikkelaar en fabrikant van digitale microscopen voor het monitoren van celkweekprocessen, ontvangt een groeifinanciering van 5,2 miljoen euro....
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl